Covalent inhibitors of Kras G12C
US9227978B2 · kind B2 · utility
45Cited by
13References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/58
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.